Literature DB >> 11091141

Differential effects of PPARalpha activators on induction of ectopic expression of tissue-specific fatty acid binding protein genes in the mouse liver.

K Motojima1.   

Abstract

The effect of a potent peroxisome proliferator-activated receptor (PPAR) alpha activator Wy14,643 on tissue-specific expression of fatty acid binding (FABP) genes was studied. Wy14,643 immediately induced liver-, intestine- and FABP but not PPARgamma-regulated adipose-FABP (or aP2) mRNAs in respective mouse tissues. Moreover, it gradually induced ectopic expression of heart- and adipose-FABP mRNAs to significant levels in the liver. However, ectopic expression was not induced in the liver of PPARalpha-null mouse, indicating an obligatory role of the receptor in the modulated expression. Among the four PPARalpha activators examined, only Wy14,643 induced ectopical expression of heart-FABP in the liver. Thus, tissue-specificity of the FABP gene expression is not absolute and, with a potent activator, can be distorted by PPARalpha.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11091141     DOI: 10.1016/s1357-2725(00)00046-7

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  15 in total

1.  Peroxisome proliferator-activated receptor ligand MCC-555 suppresses intestinal polyps in ApcMin/+ mice via extracellular signal-regulated kinase and peroxisome proliferator-activated receptor-dependent pathways.

Authors:  Kiyoshi Yamaguchi; Maria Cekanova; Michael F McEntee; Joo-Heon Yoon; Susan M Fischer; Ingrid B Renes; Isabelle Van Seuningen; Seung Joon Baek
Journal:  Mol Cancer Ther       Date:  2008-09       Impact factor: 6.261

Review 2.  Intracellular lipid binding proteins of the small intestine.

Authors:  Luis B Agellon; Matthew J Toth; Alan B R Thomson
Journal:  Mol Cell Biochem       Date:  2002-10       Impact factor: 3.396

3.  Analysis of tissue-specific and PPARalpha-dependent induction of FABP gene expression in the mouse liver by an in vivo DNA electroporation method.

Authors:  Kensei Fujishiro; Yuka Fukui; Osamu Sato; Kohei Kawabe; Koichi Seto; Kiyoto Motojima
Journal:  Mol Cell Biochem       Date:  2002-10       Impact factor: 3.396

4.  Role of adipocyte lipid-binding protein (ALBP) and acyl-coA binding protein (ACBP) in PPAR-mediated transactivation.

Authors:  Torben Helledie; Claus Jørgensen; Marianne Antonius; Ann M Krogsdam; Irina Kratchmarova; Karsten Kristiansen; Susanne Mandrup
Journal:  Mol Cell Biochem       Date:  2002-10       Impact factor: 3.396

5.  Brain fatty acid-binding protein and omega-3/omega-6 fatty acids: mechanistic insight into malignant glioma cell migration.

Authors:  Raja Mita; Michael J Beaulieu; Catherine Field; Roseline Godbout
Journal:  J Biol Chem       Date:  2010-09-12       Impact factor: 5.157

6.  Organotypic modeling of human keratinocyte response to peroxisome proliferators.

Authors:  Carmen Zhang; Igor Gurevich; Brian J Aneskievich
Journal:  Cells Tissues Organs       Date:  2012-06-05       Impact factor: 2.481

7.  An isocaloric PUFA diet enhances lipid uptake and weight gain in aging rats.

Authors:  Trudy D Woudstra; Laurie A Drozdowski; Gary E Wild; M T Clandinin; Luis B Agellon; Alan B R Thomson
Journal:  Lipids       Date:  2004-04       Impact factor: 1.880

Review 8.  Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets.

Authors:  Masato Furuhashi; Gökhan S Hotamisligil
Journal:  Nat Rev Drug Discov       Date:  2008-06       Impact factor: 84.694

9.  Association between the PPARalpha-L162V polymorphism and components of the metabolic syndrome.

Authors:  Julie Robitaille; Charles Brouillette; Alain Houde; Simone Lemieux; Louis Pérusse; André Tchernof; Daniel Gaudet; Marie-Claude Vohl
Journal:  J Hum Genet       Date:  2004-08-10       Impact factor: 3.172

Review 10.  Zebrafish as a Model for the Study of Lipid-Lowering Drug-Induced Myopathies.

Authors:  Magda Dubińska-Magiera; Marta Migocka-Patrzałek; Damian Lewandowski; Małgorzata Daczewska; Krzysztof Jagla
Journal:  Int J Mol Sci       Date:  2021-05-26       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.